Acute Lymphoblastic Leukemia Clinical Trials in Hangzhou, Zhejiang
17 recruitingHangzhou, Zhejiang, China
Showing 1–17 of 17 trials
Recruiting
Phase 1Phase 2
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen281 enrolled86 locationsNCT04521231
Recruiting
Early Phase 1
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Zhejiang University16 enrolled1 locationNCT07429461
Recruiting
Phase 1Phase 2
A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
Acute Lymphoblastic Leukemia
MSD R&D (China) Co., Ltd.203 enrolled11 locationsNCT05579132
Recruiting
Phase 1Phase 2
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Excyte Biopharma Ltd46 enrolled12 locationsNCT06580301
Recruiting
Phase 2
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Relapsed or Refractory Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.100 enrolled11 locationsNCT04684147
Recruiting
Not Applicable
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
Acute Lymphoblastic Leukemia, B-precursor
First Affiliated Hospital of Zhejiang University114 enrolled1 locationNCT07003737
Recruiting
Early Phase 1
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Zhejiang University15 enrolled1 locationNCT06793241
Recruiting
Phase 2
Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Precursor B-Cell Acute Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University36 enrolled1 locationNCT06754267
Recruiting
Phase 2
Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
Precursor B-Cell Acute Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University20 enrolled1 locationNCT06742515
Recruiting
Early Phase 1
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
T Acute Lymphoblastic Leukemia
Zhejiang University30 enrolled1 locationNCT06633354
Recruiting
Early Phase 1
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell
Zhejiang University20 enrolled1 locationNCT06346912
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06393335
Recruiting
Early Phase 1
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma
He Huang72 enrolled1 locationNCT04227015
Recruiting
Early Phase 1
CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies
Acute Lymphoblastic Leukemia, in RelapseMultiple Myeloma in RelapseMultiple Myeloma, Refractory+3 more
Zhejiang University120 enrolled1 locationNCT04603872
Recruiting
Early Phase 1
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies
Acute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue
Zhejiang University120 enrolled1 locationNCT04532281
Recruiting
Early Phase 1
A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
Zhejiang University72 enrolled1 locationNCT04532203
Recruiting
Early Phase 1
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma,B Cell
Zhejiang University72 enrolled1 locationNCT04532268